human
embryon
kidney
hek
cell
human
rhabdomyosarcoma
cell
rd
human
cervic
carcinoma
cell
hela
human
colorect
cell
vero
cell
human
monocyt
obtain
atcc
manassa
va
usa
maintain
dulbecco
modifi
eagl
medium
dmem
gibco
shanghai
china
supplement
penicillinstreptomycin
vv
fetal
bovin
serum
fb
gibco
work
approv
jinan
matern
child
care
hospit
enteroviru
shenzhen
strain
genbank
access
number
infect
perform
follow
vero
cell
use
produc
human
briefli
vero
cell
seed
dish
prior
infect
dispers
dmem
follow
inocul
vero
cell
approxim
confluenc
ad
dmem
supplement
fb
infect
allow
proceed
monolay
show
cytopath
effect
cpe
cultur
medium
cell
harvest
subject
three
cycl
centrifug
g
perform
supernat
transfer
cryovial
store
tissu
cultur
infecti
dose
ml
titrat
determin
viru
follow
briefli
seed
rd
cellswel
plate
dmem
supplement
fb
dilut
use
dilut
viru
dilut
ad
separ
well
plate
underw
incub
day
use
microscopi
cpe
analyz
endpoint
calcul
employ
determin
enteroviru
infect
vero
rd
hela
cell
perform
specif
inocul
monolay
cell
approxim
confluenc
multipl
infect
moi
h
adsorpt
incub
cultur
medium
without
fb
use
wash
cell
remov
free
viru
fresh
cultur
medium
supplement
fb
ad
cell
harvest
examin
indic
time
point
pregnant
mice
icr
provid
vital
river
beij
china
mice
rais
room
separ
ventil
cage
system
mice
age
two
week
infect
either
steril
pb
dose
via
intraperiton
rout
diseas
manifest
weight
observ
record
everi
day
follow
infect
anim
sacrif
four
five
day
posterior
paralysi
appear
muscl
tissu
spleen
heart
lung
brain
kidney
small
intestin
whole
blood
harvest
rna
extract
experi
follow
institut
guidelin
anim
research
approv
obtain
ethic
committe
jinan
matern
child
care
hospit
shenzhen
strain
monoclon
antibodi
purchas
abcam
ca
usa
santa
cruz
biotechnolog
inc
santa
cruz
ca
usa
detect
indic
protein
western
blot
goat
igg
conjug
tritc
tetramethyl
rhodamin
isothiocyan
secondari
antibodi
purchas
zhongshan
golden
bridg
biotechnolog
beij
china
use
immunofluoresc
assay
ifa
cell
lyse
ripa
buffer
ph
mm
trishcl
mm
nacl
sd
contain
proteas
inhibitor
cocktail
bca
protein
quantit
kit
use
determin
protein
concentr
sdspage
use
separ
protein
sampl
electr
transfer
onto
immobilon
pvdf
membran
membran
block
bsa
bovin
serum
albumin
pbst
triton
ad
pb
room
temperatur
h
follow
overnight
incub
follow
antibodi
rabbit
mous
amersham
ecl
goat
igg
igg
secondari
antibodi
incub
membran
h
blot
scanner
supersign
west
femto
maximum
sensit
substrat
kit
thermo
fisher
scientif
waltham
usa
use
detect
western
blot
immunoreact
total
rna
extract
cell
indic
treatment
use
trizol
reagent
invitrogen
carlsbad
ca
usa
accord
manufactur
instruct
level
mrna
determin
use
sybr
green
master
mix
thermo
fisher
scientif
incorpor
roch
lightcycl
pcr
system
roch
basel
switzerland
gapdh
use
intern
control
sequenc
primer
use
shown
tabl
quantit
pcr
perform
volum
use
sybr
green
pcr
master
mix
lightcycl
follow
condit
min
cycl
level
mrna
calcul
normal
endogen
refer
rel
calibr
mean
control
sampl
viru
infect
rd
cell
grown
plate
cover
slide
perform
moi
paraformaldehyd
pb
use
fix
cell
h
room
temperatur
permeabil
cell
pbst
perform
follow
incub
pbst
includ
bsa
subsequ
incub
polyclon
antibodi
dilut
pbst
includ
bsa
follow
pbst
wash
cell
underw
incub
goat
antibodi
dilut
bsa
pbst
next
cell
wash
h
pbst
dapi
use
stain
nuclei
cell
confoc
laser
scan
fluoresc
microscop
olympu
olympu
tokyo
japan
employ
analyz
stain
cell
scrambl
control
purchas
genscript
shanghai
china
artifici
chemic
modifi
mirna
mimic
matur
endogen
transfect
cell
concentr
suspend
nacl
final
storag
concentr
agomir
rna
analog
matur
chemic
modifi
conjug
cholesterol
moieti
promot
specif
stabil
assay
treatment
vivo
ribobio
guangdong
china
inject
intraven
tail
vein
dose
nmol
dilut
pb
per
mous
three
day
infect
potenti
target
identifi
combin
algorithm
use
mirdb
http
wwwmirdborg
target
predict
algorithm
analyz
candid
select
accord
function
amplif
gene
perform
insert
luciferas
gene
bind
site
gene
destroy
mutagenesi
mutant
select
control
transfect
effici
adjust
thymidin
kinas
promot
vector
takara
beij
china
renilla
luciferas
gene
contain
plasmid
cotransfect
luciferas
report
vector
conduct
differ
cell
line
transfect
reagent
luciferas
assay
perform
accord
manufactur
instruct
myllicin
avoid
possibl
fungal
andor
bacteri
infect
handl
experi
ad
cell
cultur
dmem
supplement
fb
follow
incub
medium
chang
everi
two
day
trypsin
use
detach
cell
follow
subcultur
cell
reach
confluenc
data
present
mean
standard
deviat
student
employ
comparison
valu
p
consid
statist
signific
p
p
p
express
vero
rd
hela
cell
examin
h
infect
virion
protein
express
found
markedli
increas
six
cell
line
infect
protein
mrna
level
fig
b
indic
success
infect
found
express
signific
decreas
infect
cell
line
especi
rd
cell
next
mice
util
examin
express
vivo
inject
abdomen
mice
sacrif
either
four
five
day
follow
appear
sever
posterior
paralysi
pcr
analysi
reveal
viru
mainli
local
lung
muscl
fig
rel
low
titer
spleen
brain
liver
intestin
express
level
differ
tissu
examin
observ
signific
decreas
express
muscl
intestin
lung
brain
fig
taken
togeth
data
demonstr
mainli
replic
muscl
downregul
muscl
induc
infect
verifi
pcr
fig
confirm
whether
infect
caus
robust
product
cytokin
pcr
western
blot
conduct
assess
express
protein
mrna
level
infect
human
colorect
vero
rhabdomyosarcoma
cell
fig
show
express
three
cell
line
significantli
increas
group
pcr
data
confirm
mrna
level
significantli
elev
infect
especi
rd
cell
fig
next
mous
model
util
evalu
rel
express
sever
tissu
expect
excess
product
cytokin
observ
muscl
lung
tissu
fig
data
clearli
demonstr
invas
induc
cytokin
product
vitro
vivo
human
colorect
vero
rhabdomyosarcoma
cell
infect
andor
transfect
multipl
growth
curv
determin
assess
influenc
replic
shown
fig
viral
growth
rate
significantli
reduc
cell
virion
protein
examin
protein
mrna
level
indic
time
point
shown
fig
express
significantli
decreas
transfect
especi
rd
cell
express
pattern
markedli
reduc
decreas
viral
protein
consist
pcr
result
show
mrna
level
significantli
reduc
group
compar
nontreat
group
fig
perform
ifa
visual
infect
rd
cell
shown
fig
level
cell
treat
significantli
less
nontreat
group
result
suggest
significantli
decreas
viral
titer
differ
cell
line
confirm
effect
cytokin
product
cellular
level
pcr
perform
evalu
level
cytokin
interferon
importantli
found
three
essenti
cytokin
cell
gradual
induc
differ
stage
infecti
cycl
howev
express
kept
moder
level
examin
time
point
postinfect
group
fig
furthermor
cytokin
rd
cell
examin
western
blot
group
cytokin
express
significantli
increas
product
clearli
suppress
express
fig
result
indic
amelior
robust
cytokin
storm
induc
later
stage
infect
enteroviru
viral
infect
induc
multipl
innat
immun
signal
pathway
especi
receptor
rlr
pathway
determin
whether
pathway
play
essenti
role
host
innat
immun
respons
infect
analysi
two
key
sensor
perform
transcript
translat
level
infect
andor
treatment
fig
protein
express
cell
show
signific
differ
nontransfect
cell
howev
express
decreas
transfect
compar
cell
induc
addit
phosphoryl
indic
activ
reduc
phosphoryl
consist
result
pcr
data
suggest
effici
downregul
observ
rd
cell
treat
lower
detect
group
compar
nontreat
group
fig
togeth
data
demonstr
regul
inflamm
product
via
signal
pathway
bioinformat
analysi
identifi
key
immun
sensor
rlr
innat
immun
respons
infect
function
put
target
fig
report
assay
conduct
six
cell
line
vero
rd
hela
investig
direct
bind
data
show
transfect
decreas
luciferas
activ
report
fuse
fig
furthermor
examin
express
six
cell
line
infect
andor
transfect
use
pcr
western
blot
shown
fig
express
suppress
express
protein
mrna
level
probe
mechan
agomir
administr
attenu
replic
pathogen
anim
model
perform
pcr
assess
cytokin
level
shown
fig
confirm
ectop
express
pcr
addit
found
express
significantli
reduc
agomir
administr
suggest
antivir
effect
furthermor
level
cytokin
induc
evalu
pcr
experi
fig
shown
fig
robust
express
observ
muscl
lung
blood
spleen
tissu
mice
contrast
express
two
cytokin
markedli
inhibit
treatment
togeth
data
provid
evid
confer
inhibitori
effect
cytokin
storm
therefor
amelior
damag
caus
studi
inhibitori
role
replic
pathogen
infect
observ
vitro
vivo
express
pattern
viral
protein
decreas
treatment
furthermor
found
abl
amelior
robust
innat
immun
respons
differ
stage
infect
target
immun
sensor
decreas
express
increas
evid
demonstr
excess
inflammatori
signal
occur
organ
injuri
one
main
pathogen
factor
respons
high
mortal
follow
infect
signal
pathway
regul
mani
gene
relat
cell
differenti
prolifer
innat
immun
respons
addit
via
elicit
cytokin
type
ifn
express
import
antivir
reaction
host
howev
protein
suppress
activ
increas
viru
replic
viral
protein
suppress
phosphoryl
via
bind
kinas
domain
reduc
activ
promot
viral
replic
studi
administr
result
deactiv
express
inhibit
replic
result
could
attribut
robust
cytokin
believ
contribut
pathogen
amelior
express
indic
moder
level
cytokin
interferon
maintain
limit
effect
howev
molecular
mechan
control
express
viral
replic
infect
still
need
research
investig
possibl
whether
inhibit
inflamm
propag
separ
practic
implic
evolut
suggest
sequenc
conserv
nucleotid
level
differ
speci
rather
vari
express
pattern
although
sequenc
conserv
express
profil
differ
significantli
variou
speci
extens
investig
variou
biolog
process
npc
prolifer
migrat
neuron
differenti
apoptot
cell
death
brain
function
neurodegener
cancer
moreov
accumul
evid
suggest
requir
replic
multipl
virus
dong
et
al
indic
novel
function
influenza
viru
infect
found
influenza
viru
might
hijack
endogen
viral
life
cycl
tatro
et
al
suggest
hiv
infect
induc
elev
express
caus
suppress
splice
variant
may
affect
releas
neurotransmitt
lai
et
al
report
nucleocapsid
protein
human
coronaviru
caus
activ
activ
consequ
nucleocapsid
bind
rna
specif
neg
modul
found
studi
studi
suggest
neg
mediat
replic
vitro
vivo
ectop
express
cell
result
inactiv
amelior
excess
cytokin
product
potenti
lessen
organ
injuri
induc
cytokin
storm
viru
infect
data
impli
antivir
activ
relat
regul
releas
cytokin
signal
transduct
via
decreas
activ
express
studi
may
provid
new
insight
infect
suppress
work
bl
jz
conceiv
studi
design
experi
contribut
data
collect
perform
data
analysi
interpret
result
bl
wrote
manuscript
jz
contribut
critic
revis
articl
author
read
approv
final
manuscript
